Global X China Little Giant ETF - Global X ETFs Hong Kong
1763927881
Hong Kong (SAR)
Our Products Research
Subscribe Search

Global X China Little Giant ETF

2815 HKD

Invest in 2815
Explore More

Important Information

Investors should not base investment decisions on this material alone. Please refer to the Prospectus for details including the product features and the risk factors. Investment involves risks. Past performance is not indicative of future performance. There is no guarantee of the repayment of the principal. Investors should note:

  • The investment objective of Global X China Little Giant ETF (the “Fund”) is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China Little Giant Index.
  • The Fund is exposed to concentration risk by tracking a single regions or countries.
  • The Fund may invest in small and/or mid-sized companies, which may have lower liquidity and their prices are more volatile to adverse economic developments.
  • Investment in Emerging Market, such as A-share market, may involve increased risks and special considerations not typically associated with investments in more developed markets, such as liquidity risk, currency risks, political risk, legal and taxation risks, and the likelihood of a high degree of volatility.
  • The Stock Connect is subject to quota limitations. Where a suspension in the trading through the Stock Connect is effected, the Sub-Fund’s ability to invest in A-Shares or access Mainland China markets through the programme will be adversely affected.
  • Listed companies on the ChiNext market and/or STAR Board are usually subject to higher fluctuation in stock prices and liquidity risks, over-valuation risk, differences in regulation, delisting risk, and concentration risk.
  • There are risks and uncertainties associated with the current Mainland China tax laws, regulations and practice in respect of capital gains realized via Stock Connect on the Fund’s investments in Mainland China. Any increased tax liabilities on the Fund may adversely affect the Fund’s value.
  • The trading price of the Fund’s unit on the SEHK is driven by secondary market trading factors, which may lead to a substantial premium or discount to the Fund’s net asset value.
  • The Fund’s synthetic replication strategy may invest up to 50% of its net asset value in financial derivative instruments (“FDIs”), which may expose the Fund to counterparty/credit risk, liquidity risk, valuation risk, volatility risk and over-the-counter transaction risk. The Fund may suffer losses from its usage of FDIs.
  • The Manager may at its discretion pay dividends out of the capital of the Fund. Distributions paid out of capital, represent a return of an investor’s original investment or its gains and may potentially reduce the Fund’s Net Asset Value per Share as well as the capital available for future investment.
  • The Fund may suffer from a losses or delays when recovering the securities lent out. This may potentially affect its ability to meet payment and redemption obligations. Collateral shortfalls due to inaccurate pricing or change of value of securities lent, may cause significant losses to the Fund.

Why Global X China Little Giant ETF? Key Info and Charts 

  • China‘s economy is transitioning to high-quality one. Specialized and sophisticated SMEs「專精特新小巨人」is a key tool for China to achieve it.
  • “Little Giant” companies are high-quality small-cap companies in China’s strategic industries. They are industry leaders in niche markets and play a crucial role in the supply chain for China’s high-end manufacturing sector.
  • “Little Giant” companies receive strong support from the government and society.

Fund InformationAs of 20 Nov 2025

Fund Inception Date 17 Nov 2023
SEHK Listing Date 20 Nov 2023
Fiscal Year Ending 31 Mar
Ongoing Charges Over A Year ^ 0.68%
Distribution Frequency Annually (usually in May of each year) at the Manager’s discretion.*
NAV Per Share RMB ¥54.69
Fact Sheet
^ The Fund (Listed Class) adopts a single management fee structure, whereby a single flat fee will be paid out of the assets of the Fund to cover all of the costs, fees and expenses of the Fund. Click to learn more. * Dividend is not guaranteed, distributions may be made out of capital or income at the Manager’s discretion. Positive distribution does not imply positive return. Please refer to the IMPORTANT INFORMATION section above and the Fund’s prospectus for further details.

Index Information1As of 20 Nov 2025

Underlying Index Solactive China Little Giant Index 2
Index Type Net Total Return
Base Currency RMB
Closing Level 156.45
Change -1.64
Change % -1.04%

Trading InformationAs of 20 Nov 2025

HKD Traded Units3
Exchange Hong Kong Exchange
Stock Code 2815
ISIN HK0000945656
Board Lot Size 50 Units
Trading Currency HKD
Base Currency RMB
Total Net Asset Value $29,287,241.51
Outstanding Units 489,750

ETF Summary

Global X China Little Giant ETF provides investors with access to potential small- and medium-sized companies in strategic areas such as semiconductors, advanced manufacturing, pharmaceuticals and clean energy etc. With the continuous development of proprietary products and technologies, the innovation and profitability of Chinese specialized "Little Giant" companies will be further enhanced, and they are expected to achieve even faster growth, and investors in this ETF may benefit from the continued transformation of Chinese economic structure and the upgrading of industrial chain.

The investment objective is to provide investment returns that closely correspond to the performance of the Solactive China Little Giant Index (the "Index"), net of fees and expenses.

Research

View More Related Research

ETF Prices

* Market prices are provided on a 15-minute delayed basis by ICE Data Services. (See terms and conditions)

Daily NAV per Unit5As of 20 Nov 2025

NAV Change % Change
Official NAV per Unit in RMB ¥54.69 ¥-0.57 -1.04%
NAV per Unit in HKD 3 $59.80 $-0.63 -1.04%

Performance As of 20 Nov 2025

Cumulative Return Fund NAV (%) Benchmark (%)
1 Mth -4.03 -3.97
3 Mths 1.44 1.61
6 Mths 23.37 23.96
1 Yr 20.03 21.08
YTD 27.66 28.70
Since Inception 8.55 10.39
Calendar Year Return Fund NAV (%) Benchmark (%)
2024 -11.77 -11.02
2023 - -
2022 - -
2021 - -
2020 - -
Source: Mirae Asset Global Investments (Hong Kong) Limited.
• Past performance information is not indicative of future performance. Investors may not get back the full amount invested.
• The computation basis of the performance is based on the calendar year end, NAV-to-NAV, with dividend reinvested.
• These figures show by how much the Fund increased or decreased in value during the calendar year shown.
• Performance data has been calculated in RMB including ongoing charges and excluding trading costs on SEHK you might have to pay.
• Where no past performance is shown there was insufficient data available in that year to provide performance.
• The Index of the Fund is Solactive China Little Giant Index.
• Fund inception date: 17 Nov, 2023.

Exposure As of 31 Oct 2025

    Weight (%)
Information Technology 61.0
Health Care 15.5
Industrials 10.9
Consumer Discretionary 6.9
Materials 5.4
Cash 0.2
    Weight (%)
China 99.8
Cash 0.2

Holdings Overview As of 20 Nov 2025

Total Net Asset Value (in HKD) Total Net Asset Value (in USD) Total Net Asset Value (in RMB) Number of Securities Securities (%) Cash and Cash Equivalent (%)
29,287,241.51 3,763,115.23 26,785,477.88 50 99.92 0.08

Daily HoldingsAs of 20 Nov 2025

Name of Securities Exchange Ticker Exchange Market Price (in RMB) Number of Shares Held Market Value (in RMB) Net Assets (%)
SUZHOU TFC OPTICAL COMMUNI 300394 CH Shenzhen 160.08 13,530 2,165,882.40 8.09
ACM RESEARCH SHANGHAI I 688082 CH Shanghai 160.90 10,229 1,645,846.10 6.14
ROCKCHIP ELECTRONICS CO L 603893 CH Shanghai 168.67 7,666 1,293,024.22 4.83
PIOTECH INC 688072 CH Shanghai 307.85 3,390 1,043,611.50 3.90
IMEIK TECHNOLOGY DEVELOPME 300896 CH Shenzhen 150.84 6,571 991,169.64 3.70
SG MICRO CORP 300661 CH Shenzhen 66.13 14,247 942,154.11 3.52
SHANGHAI BOCHU ELECTRONIC 688188 CH Shanghai 132.06 6,824 901,177.44 3.36
APT MEDICAL INC 688617 CH Shanghai 261.35 3,313 865,852.55 3.23
SHENZHEN TECHWINSEMI TECHN 001309 CH Shenzhen 247.46 3,208 793,851.68 2.96
HWATSING TECHNOLOGY 688120 CH Shanghai 131.55 5,980 786,669.00 2.94
ANJI MICROELECTRONICS TECH 688019 CH Shanghai 194.02 3,842 745,424.84 2.78
KEBODA TECHNOLOGY 603786 CH Shanghai 70.16 9,443 662,520.88 2.47
ASYMCHEM LABORATORIES TIAN 002821 CH Shenzhen 91.00 7,215 656,565.00 2.45
ZHEJIANG CHANGSHENG SLIDIN 300718 CH Shenzhen 81.65 7,344 599,637.60 2.24
KINGSEMI 688037 CH Shanghai 126.05 4,721 595,082.05 2.22
DALIAN BAIAO CHEMICALS 603360 CH Shanghai 31.93 18,020 575,378.60 2.15
BEIJING HUAFENG TEST & CON 688200 CH Shanghai 170.61 3,375 575,808.75 2.15
STARPOWER SEMICONDUCTOR LT 603290 CH Shanghai 97.57 5,550 541,513.50 2.02
GIANTEC SEMICONDUCTOR CORP 688123 CH Shanghai 135.71 3,790 514,340.90 1.92
HEBEI SINOPACK ELECTRONIC 003031 CH Shenzhen 51.83 9,868 511,458.44 1.91
AUTEL INTELLIGENT TECHNOLO 688208 CH Shanghai 33.36 15,104 503,869.44 1.88
IRAY GROUP 688301 CH Shanghai 102.30 4,653 476,001.90 1.78
BEIJING BALANCE MEDICAL TE 688198 CH Shanghai 131.90 3,285 433,291.50 1.62
WILLFAR INFORMATION TECHNO 688100 CH Shanghai 35.27 11,448 403,770.96 1.51
SUZHOU RECODEAL INTERCONNE 688800 CH Shanghai 71.65 5,122 366,991.30 1.37
HARBIN BOSHI AUTOMATION 002698 CH Shenzhen 15.17 23,612 358,194.04 1.34
XI'AN TRIANGLE DEFENSE 300775 CH Shenzhen 28.29 12,664 358,264.56 1.34
PYLON TECHNOLOGIES 688063 CH Shanghai 61.72 5,667 349,767.24 1.31
WUXI NCE POWER 605111 CH Shanghai 35.65 9,500 338,675.00 1.26
ANHUI XDLK MICROSYSTEM COR 688582 CH Shanghai 56.01 5,974 334,603.74 1.25
CIRCUIT FABOLOGY MICROELEC 688630 CH Shanghai 112.96 2,806 316,965.76 1.18
NOVORAY CORP 688300 CH Shanghai 55.40 5,563 308,190.20 1.15
SINOFIBERS TECHNOLOGY CO L 300777 CH Shenzhen 30.66 10,048 308,071.68 1.15
JIANGSU BOJUN INDUSTRIAL T 300926 CH Shenzhen 29.76 10,044 298,909.44 1.12
QINGDAO YUNLU ADVANCED MAT 688190 CH Shanghai 102.16 2,927 299,022.32 1.12
CHINA LEADSHINE TECHNOLOGY 002979 CH Shenzhen 38.30 7,647 292,880.10 1.09
ZHEJIANG LANTE OPTICS CO L 688127 CH Shanghai 29.28 9,714 284,425.92 1.06
SINOPEP-ALLSINO BIO PHARMA 688076 CH Shanghai 38.41 7,238 278,011.58 1.04
DONGGUAN AOHAI TECHNOLOGY 002993 CH Shenzhen 42.25 6,586 278,258.50 1.04
SOUTHCHIP SEMICONDUCTOR TE 688484 CH Shanghai 39.93 6,938 277,034.34 1.03
EYEBRIGHT MEDICAL TECHNOLO 688050 CH Shanghai 61.00 4,432 270,352.00 1.01
MEIG SMART TECH 002881 CH Shenzhen 41.15 6,324 260,232.60 0.97
ARCTECH SOLAR HOLDING CO L 688408 CH Shanghai 49.52 5,139 254,483.28 0.95
SHANGHAI FULLHAN MICROELEC 300613 CH Shenzhen 44.27 5,718 253,135.86 0.95
CHENGDU RML TECHNOLOGY 301050 CH Shenzhen 44.46 5,722 254,400.12 0.95
SHANGHAI MICROPORT ENDOVAS 688016 CH Shanghai 94.09 2,660 250,279.40 0.93
KUNSHAN DONGWEI TECHNOLOGY 688700 CH Shanghai 35.15 7,016 246,612.40 0.92
CHENGDU HAONENG TECHNOLOGY 603809 CH Shanghai 11.84 20,240 239,641.60 0.89
BEIJING YUANLIU HONGYUAN E 603267 CH Shanghai 45.92 5,048 231,804.16 0.87
WUHAN TIANYUAN GROUP CO LT 301127 CH Shenzhen 13.97 16,441 229,680.77 0.86
Source: Mirae Asset, Bloomberg
Holdings are subject to change. Cash, where shown, includes other assets and liabilities, such as payables and receivables.
20251120-1.0384-1.0373837687393

Tracking Difference / Error

Tracking Difference / Tracking Error

Tracking Difference
Tracking difference is the return difference between the Fund and the Underlying Index over a certain period of time.
Tracking Error
Tracking error measures how consistently the Fund follows the Underlying Index. It is the volatility (measured by standard deviation) of that return difference.

Tracking Difference (TD)

Fund Listing Date:20 Nov 2023

Estimated Annual TD: -2.00%

TD (Since Listing): N/A%

TD for Calendar Year 2024:-0.75%

Tracking Error (TE)

Fund Listing Date:20 Nov 2023

Rolling 1 Year TE^ :N/A%

^ Annualized based on the number of dealing days in the past year when daily TD is calculated.


Graph for Tracking Difference

ETFs performance is calculated on an NAV to NAV basis and assumes reinvestment of distribution.

Hover over the chart points for details

Market Makers 6

Mirae Asset Securities Co., Ltd

Optiver Trading Hong Kong Limited

Flow Traders Hong Kong Limited

Participating Dealers 7

China Merchants Securities (HK) Co., Limited

DBS Vickers (Hong Kong) Limited

Haitong International Securities Company Limited

Mirae Asset Securities (HK) Limited

Valuable Capital Limited

Back to Top

You’re now leaving Global X Hong Kong website


Clicking "Confirm" below will take you to an independent site. Information and services provided on this independent site are not reviewed by, guaranteed by, or Global X Hong Kong. This independent site's terms and conditions, privacy and security policies, or other legal information may be different from those of Global X Hong Kong’s site. Global X Hong Kong is not liable for any direct or indirect technical or system issues, consequences, or damages arising from your use of this independent website.



CancelConfirm

This website is intended for Hong Kong investors only. Your use of this website means you agree to our Terms of use. This website is strictly for informational purposes only and does not constitute a representation that any investment strategy is suitable or appropriate for an investor’s individual circumstances. In 2018, Global X was acquired by Mirae Asset Global Investments and Mirae Asset Global Investments Co., Ltd. is the parent company of Mirae Asset Global Investments (Hong Kong) Limited.

The information contained in this website is for information purposes only and does not, constitute any recommendations, offer or solicitation to buy, sell or subscribe to any securities or financial instruments in any jurisdiction. Investment involves risk. It cannot be guaranteed that the performance of the Product will generate a return and there may be circumstances where no return is generated or the amount invested is lost. Past performance is not indicative of future performance.

Before making any investment decision to invest in the Product, investors should read the Product’s prospectus for details and the risk factors. Investors should ensure they fully understand the risks associated with the Product and should also consider their own investment objective and risk tolerance level. Investors are advised to seek independent professional advice before making any investments.

Certain information contained in this website is compiled from third party sources. Whilst Mirae Asset Global Investments (Hong Kong) Limited (“Mirae Asset HK”), the Manager of the Product, has, to the best of its endeavor, ensured that such, information is accurate, complete and up-to-date, and has taken care in accurately reproducing the information. Mirae Asset HK accepts no liability for, any loss or damage of any kind resulting out of the unauthorized use of this website.

The Products are not sponsored, endorsed, issued, sold or promoted by their index providers. For details of an index provider including any disclaimer, please refer to the relevant Product’s offering documents.

The contents of this website is prepared and maintained by Mirae Asset Global Investments (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.